Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.
- Published In:
- Journal of hepatology, 81(4), 621-629 (2024)
- Authors:
- Wedemeyer, Heiner(2), Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Berger, Annemarie, Ciesek, Sandra, Manuilov, Dmitry, Mercier, Renee-Claude, Da, Ben L, Chee, Grace M, Li, Mingyang, Flaherty, John F, Lau, Audrey H, Osinusi, Anu, Schulze Zur Wiesch, Julian, Cornberg, Markus, Zeuzem, Stefan, Lampertico, Pietro
- Database ID:
- RPEP-09513
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-09513APA
Wedemeyer, Heiner; Aleman, Soo; Brunetto, Maurizia; Blank, Antje; Andreone, Pietro; Bogomolov, Pavel; Chulanov, Vladimir; Mamonova, Nina; Geyvandova, Natalia; Morozov, Viacheslav; Sagalova, Olga; Stepanova, Tatyana; Berger, Annemarie; Ciesek, Sandra; Manuilov, Dmitry; Mercier, Renee-Claude; Da, Ben L; Chee, Grace M; Li, Mingyang; Flaherty, John F; Lau, Audrey H; Osinusi, Anu; Schulze Zur Wiesch, Julian; Cornberg, Markus; Zeuzem, Stefan; Lampertico, Pietro. (2024). Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.. Journal of hepatology, 81(4), 621-629. https://doi.org/10.1016/j.jhep.2024.05.001
MLA
Wedemeyer, Heiner, et al. "Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase III randomized trial.." Journal of hepatology, 2024. https://doi.org/10.1016/j.jhep.2024.05.001
RethinkPeptides
RethinkPeptides Research Database. "Bulevirtide monotherapy in patients with chronic HDV: Effica..." RPEP-09513. Retrieved from https://rethinkpeptides.com/research/wedemeyer-2024-bulevirtide-monotherapy-in-patients
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.